Does ENASIDENIB Cause Off label use? 213 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 213 reports of Off label use have been filed in association with ENASIDENIB (Idhifa). This represents 5.8% of all adverse event reports for ENASIDENIB.
213
Reports of Off label use with ENASIDENIB
5.8%
of all ENASIDENIB reports
26
Deaths
35
Hospitalizations
How Dangerous Is Off label use From ENASIDENIB?
Of the 213 reports, 26 (12.2%) resulted in death, 35 (16.4%) required hospitalization, and 3 (1.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENASIDENIB. However, 213 reports have been filed with the FAERS database.
What Other Side Effects Does ENASIDENIB Cause?
Death (650)
Fatigue (202)
Nausea (197)
Acute myeloid leukaemia (163)
Hospitalisation (149)
Diarrhoea (144)
Decreased appetite (122)
Platelet count decreased (113)
Drug ineffective (108)
Differentiation syndrome (102)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ENASIDENIB Alternatives Have Lower Off label use Risk?
ENASIDENIB vs ENBREL
ENASIDENIB vs ENCORAFENIB
ENASIDENIB vs ENDOXAN
ENASIDENIB vs ENDOXAN BAXTER
ENASIDENIB vs ENDOXAN INJ